The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function and even improving movement in some patients.
More in Research
Ozempic and Wegovy linked to rare risk of sudden vision loss
October 15, 2026
A 47-year study reveals the age when your body starts losing strength
October 15, 2026
Scientists reveal 93% of Australia's Indigenous population was lost in just 73 years
October 14, 2026
A forgotten fossil reveals a fearsome dinosaur with giant claws
October 14, 2026
Cancer is rising in younger adults, and scientists can't fully explain why
October 14, 2026
Scientists reveal why some workout recovery tricks can backfire
October 14, 2026
Latest News
Sony made a $5,900 gold-plated Walkman MP3 player
October 15, 2026
Trump calls off livestream of Fort Hood attacker's execution by firing squad
October 15, 2026
Watch: What does Starlink have to do with the Ukraine-Russia war?
October 15, 2026
Alienware’s latest 34-inch QD-OLED gaming monitor is $50 off
October 15, 2026
Volvo will use Nvidia’s tech for hands-free, point-to-point driving
October 15, 2026
Google is making inline links more prominent in AI responses
October 15, 2026